Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
iCardiac Technologies, Inc. logo — company profile

iCardiac Technologies, Inc.

Founded 2006 51-200 employees Venture round Total: $4.00M Biopharma, Biotechnology +2

General Information

Company Name iCardiac Technologies, Inc.
Founded Year 2006
Employees 51-200
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with iCardiac Technologies, Inc.. To contact iCardiac Technologies, Inc., visit icardiac.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does iCardiac Technologies, Inc. compare?

A PDF of iCardiac Technologies, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting iCardiac Technologies, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About iCardiac Technologies, Inc.

is a biotech startup specializing in innovative solutions for the biopharma and healthcare industries. Founded in 2006, the company has made significant strides in its field. The last notable investment came in the form of a Venture Round investment on March 6, 2014, with Norwest Venture Partners leading the way. This injection of capital likely facilitated further advancements and expansion for the company. Now integrated into ERT, iCardiac Technologies continues to drive progress in its respective sectors. This development could potentially open up new opportunities for growth and collaboration. Furthermore, the integration could enhance iCardiac's capabilities and reach, serving as a positive signal for investors considering the company's potential. As the company operates within the fields of biopharma, biotechnology, and healthcare, it remains well-positioned to leverage its expertise for continued success. With a strong foundation and a recent infusion of capital, iCardiac Technologies could be poised for further breakthroughs and sustained growth in the near future.

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
Norwest Venture Partners
Norwest Venture Partners
06 Mar 2014
Series B Undisclosed 3
Advantage Capital Partners
Advantage Capital Partners, Trillium Group +1
14 Nov 2007
Series A $4.00M 2
Advantage Capital Partners Stonehenge Capital Company
Advantage Capital Partners, Stonehenge Capital Company
08 Nov 2006

iCardiac Technologies, Inc. Alternatives & Competitors

View All Alternatives
iCardiac Technologies, Inc. vs
Novella Clinical
Novella Clinical United States

Novella Clinical is now part of IQVIA.

203 employees
Health Care, Life Sciences
iCardiac Technologies, Inc. vs
Ironshore
Ironshore United States

Ironshore is now part of Collegium Pharmaceutical, Inc.

Private Equity
86 employees
Biotechnology, Health Care
iCardiac Technologies, Inc. vs
Arcellx
Arcellx United States

Arcellx is a clinical-stage biotechnology company based in Redwood City, California

Acquired
224 employees
Biopharma, Biotechnology
View all alternatives

FAQ About iCardiac Technologies, Inc.

iCardiac is now a part of ERT!
iCardiac Technologies, Inc. was founded in 2006.
iCardiac Technologies, Inc. operates in Biopharma, Biotechnology, Health Care and Life Sciences.
iCardiac Technologies, Inc. has approximately 51-200 employees.
iCardiac Technologies, Inc. has completed 3 funding rounds, raising a total of $4.00M. The latest funding stage is Venture round.
Top alternatives and competitors to iCardiac Technologies, Inc. include Novella Clinical, Ironshore, Arcellx, Karuna Therapeutics, Roche NimbleGen Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
iCardiac Technologies, Inc. and Novella Clinical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for iCardiac Technologies, Inc., https://bouncewatch.com/company/icardiac-technologies, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes